USMLE Forum - Largest USMLE Community

Full Version: Pharma Q - usmedipro
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
A 72-year-old male is noted as having a 9-pound weight loss
over the past few weeks. His past medical history is significant
for oat cell carcinoma of the lung, without known metastases, for
which he is currently undergoing treatment. The patient states that
even though his wife is preparing his favorite meals, he is not hungry.
Which of the following would be the best treatment option to improve his
eating habits?
A. Amitriptyline
B. Megestrol acetate
C. Methotrexate
D. Neostigmine
E. Prochlorperazine
BB
B. Megestrol acetate
I got the answer but by eclusion of others but......whyyyyyyyyyyyyyyyyyy BBB????

megestrol acetate bbbb...Megestrol acetate oral suspension (a form of Megestrol) is used primarily as an appetite enhancer. The method of appetite enhancement is not known, but it can cause high blood sugar.[1]

ok bb
BB
One of the most common side effects of any antineoplastic therapy is weight loss secondary to decreased appetite and/or nausea and vomiting. Furthermore, weight loss due to decreased food intake tends to occur more frequently in elderly patients receiving antineoplastic therapy. One medication that has consistently helped to increase appetite in such patients is megestrol acetate. This agent is a progestational hormone with antineoplastic properties used in the treatment of advanced carcinoma of the breast and endometrium. Megestrol, when given in relatively high doses, can substantially increase the appetite in most individuals, even those with advanced cance